Literature DB >> 6186499

Further evidence for multiple tachykinin receptors.

J W Growcott, A Jamieson, A V Tarpey, L D Topham.   

Abstract

Rank order potency data for substance P (SP), physalaemin and eledoisin have been determined in a variety of assays in vitro. On the guinea-pig field stimulated vas deferens, physalaemin was approximately eight and five times more potent than eledoisin and SP respectively whereas in the rat field-stimulated vas deferens, eledoisin was approximately five times more potent than either physalaemin or SP. It would appear that the guinea-pig preparation has a preponderance of 'P'-receptor subtypes, whereas the rat preparation contains mainly 'E'-receptor subtypes. We have attempted to validate the hypothesis that there are multiple tachykinin receptors. Experiments have been performed with the guinea-pig urinary bladder in vitro, using phenoxybenzamine (20 microM, 30 min) to alkylate receptor sites and using excess eledoisin (0.2-0.4 microM, 30 min) to protect receptors selectively against the effects of this agent. Our results showed that after pretreatment with phenoxybenzamine, the responses to eledoisin were significantly attenuated. Moreover, in the presence of excess eledoisin it was found that phenoxybenzamine was unable to produce any significant reduction of the subsequent responses. This difference between the responses to eledoisin and to other agonists suggests the existence of at least two different receptor subtypes for the tachykinins.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6186499     DOI: 10.1016/0014-2999(82)90396-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  In vivo and in vitro actions of mammalian tachykinins.

Authors:  U Holzer-Petsche; E Schimek; R Amann; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

2.  Receptors for neurotransmitters in opossum oesophagus muscularis mucosa.

Authors:  E E Daniel; J Jury; K H Robotham
Journal:  Br J Pharmacol       Date:  1986-07       Impact factor: 8.739

3.  Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykinins.

Authors:  X Hua; J M Lundberg; E Theodorsson-Norheim; E Brodin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

4.  Development of a new tachykinin antagonist.

Authors:  R Mathison; P Stofer; F Barja; H Immer
Journal:  Experientia       Date:  1984-01-15

5.  Extrinsic origin of the capsaicin-sensitive innervation of rat duodenum: possible involvement of calcitonin gene-related peptide (CGRP) in the capsaicin-induced activation of intramural non-adrenergic non-cholinergic neurons.

Authors:  C A Maggi; S Manzini; S Giuliani; P Santicioli; A Meli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

6.  A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon.

Authors:  S J Bailey; C C Jordan
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.